Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

36 results

Sort by

List item

Human medicine European public assessment report (EPAR): Raxone

idebenone, Optic Atrophy, Hereditary, Leber
Date of authorisation: 08/09/2015, , , , Revision: 8, Authorised, Last updated: 27/10/2022
List item

Human medicine European public assessment report (EPAR): Obizur

susoctocog alfa, Hemophilia A
Date of authorisation: 11/11/2015, , , Revision: 10, Authorised, Last updated: 26/10/2022
List item

Human medicine European public assessment report (EPAR): Evkeeza

Evinacumab, Hypercholesterolemia
Date of authorisation: 17/06/2021, , , Revision: 2, Authorised, Last updated: 12/10/2022
List item

Human medicine European public assessment report (EPAR): Brineura

cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017, , , , , Revision: 6, Authorised, Last updated: 16/08/2022
List item

Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)

split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 10/10/2009, , Revision: 11, Authorised, Last updated: 08/06/2022
List item

Human medicine European public assessment report (EPAR): Firdapse (previously Zenas)

amifampridine, Lambert-Eaton Myasthenic Syndrome
Date of authorisation: 23/12/2009, , , Revision: 21, Authorised, Last updated: 25/05/2022
List item

Human medicine European public assessment report (EPAR): Foclivia

influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 18/10/2009, , Revision: 12, Authorised, Last updated: 06/04/2022
List item

Human medicine European public assessment report (EPAR): Voraxaze

glucarpidase, Metabolic Side Effects of Drugs and Substances
Date of authorisation: 11/01/2022, , , , Authorised, Last updated: 20/01/2022
List item

Human medicine European public assessment report (EPAR): Increlex

Mecasermin, Laron Syndrome
Date of authorisation: 02/08/2007, , , Revision: 24, Authorised, Last updated: 11/01/2022
List item

Human medicine European public assessment report (EPAR): Dectova

Zanamivir, Influenza, Human
Date of authorisation: 26/04/2019, , , Revision: 4, Authorised, Last updated: 08/10/2021
List item

Human medicine European public assessment report (EPAR): Vedrop

tocofersolan, Cholestasis; Vitamin E Deficiency
Date of authorisation: 23/07/2009, , , Revision: 13, Authorised, Last updated: 22/08/2019